Prominent securities law firm Bleichmar Fonti & Auld LLP has announced it is investigating the board of directors and senior management of MediaAlpha, Inc. to assess whether they breached their fiduciary duties to shareholders concerning the company's $45 million settlement with the U.S. Federal Trade Commission.
The investigation centers on the timeline of events. In October 2024, the FTC notified MediaAlpha of its intent to file a lawsuit, alleging the company misrepresented government affiliations, made misleading statements about health insurance products, and used deceptive advertising in its lead generation business. The company disclosed this matter to shareholders in November of that year, acknowledging it "could result in a loss."
In July 2025, MediaAlpha reached a settlement with the FTC for $45 million in cash and agreed to governance reforms to restrict future advertising and marketing practices. The core issue, however, is that during the period between the FTC's initial notice and the full disclosure of the lawsuit's details to shareholders, company insiders sold significant amounts of MediaAlpha stock. This has raised serious questions about whether certain executives may have used non-public information about the litigation to sell shares at elevated prices before the negative news was fully known to the public.
The law firm is examining whether the board and officers violated their fiduciary duties to shareholders through these insider stock sales. The firm is currently gathering information from current shareholders of MediaAlpha to evaluate potential legal actions. Legal representation would be provided on a contingency fee basis, meaning shareholders would not incur any upfront costs.
This news and the regulatory scrutiny have impacted investor confidence in MediaAlpha. As of June 4, 2026, the company's share price was approximately $8.60, near its 52-week low and significantly down from recent highs. Nonetheless, some analysts maintain a "buy" rating on the stock, with an average price target of $13.20, suggesting potential for a rebound.